Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2010
03/24/2010CN101675926A Analgesics and methods of use
03/24/2010CN100595195C Preparation method and application of isoquinoline componds and salts thereof
03/23/2010US7683201 cost efficiency; environmentally friendly
03/23/2010US7683178 Method for the synthesis of a benzimidazole compound
03/23/2010US7683177 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
03/23/2010US7683176 Triazolyl pyridyl benzenesulfonamides
03/23/2010US7683091 Substituted indoles and methods of their use
03/23/2010US7683081 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
03/23/2010US7683080 purification from sulfide/sulfone derivatives; crystallization; proton pump inhibitors
03/23/2010US7683070 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide
03/23/2010US7683069 3-substituted-4-pyrimidone derivatives
03/23/2010US7683067 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
03/23/2010US7683066 Isoquinolines useful as modulators of ion channels
03/23/2010US7683065 Pyridines useful as modulators of ion channels
03/23/2010US7683064 Inhibitors of Bruton's tyrosine kinase
03/23/2010US7683063 inhibiting Vanilloid Receptor 1; Inflammatory bowel disease; Crohn's disease and ulcerative colitis; cyclo(hetero)alkenyl compound
03/23/2010US7683059 Triazole compounds and uses related thereto
03/23/2010CA2465686C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/23/2010CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof
03/23/2010CA2402467C Method for producing heterocyclic compounds
03/23/2010CA2389767C Quinazoline derivatives as vegf inhibitors
03/23/2010CA2354387C Substituted pyridine herbicides
03/18/2010WO2010031056A2 Methods and compositions for modulating ire1, src, and abl activity
03/18/2010WO2010030983A2 Pyrazole carboxamide inhibitors of factor xa
03/18/2010WO2010030967A1 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
03/18/2010WO2010030027A1 Aromatic nitrogen-containing 6-membered ring compounds and their use
03/18/2010WO2010029938A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4–fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same
03/18/2010WO2010029756A1 5-[2-(methylthio)ethoxy]pyrimidine-2-amine manufacturing method
03/18/2010WO2010029461A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010WO2010029300A1 Bis aromatic compounds for use in the treatment of inflammation
03/18/2010WO2010028981A1 New benzimidazole derivatives
03/18/2010WO2010028974A1 Imidazole and triazole compounds, use thereof and agents containing said compounds
03/18/2010WO2010028862A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010WO2010028655A1 Isoquinolinone derivatives as nk3 antagonists
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010WO2009056707A8 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
03/18/2010US20100069638 Sulfonamide derivative having pgd2 receptor antagonistic activity
03/18/2010US20100069636 Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which Have the Same
03/18/2010US20100069437 Therapeutic agents useful for treating pain
03/18/2010US20100069436 Imidazole compounds having an antiinflammatory effect
03/18/2010US20100069435 Method of selectively introducing amino substituent
03/18/2010US20100069432 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
03/18/2010US20100069417 Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitors
03/18/2010US20100069416 Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors
03/18/2010US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/18/2010US20100069412 Phosphonoxy quinazoline derivatives and their pharmaceutical use
03/18/2010US20100069404 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
03/18/2010US20100069399 Arylpiperazine modulators of d2 receptors, 5-ht1a receptors, and/or 5-ht2a receptors
03/18/2010US20100069384 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy
03/18/2010US20100069383 Compounds and therapeutical use thereof
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069375 Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
03/18/2010US20100069373 Substituted lactams as inhibitors of a beta protein production
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069365 Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors
03/18/2010US20100069364 Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments
03/18/2010US20100069363 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069353 Inhibitors of hiv replication
03/18/2010US20100069350 New Pyridine Analogues III
03/18/2010US20100069244 Pyridine Compounds for Combating Pests
03/18/2010US20100068883 Cmp slurry composition for forming metal wiring line
03/18/2010US20100068752 Novel fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
03/18/2010US20100068301 Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
03/18/2010US20100068181 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/18/2010US20100068150 Selective Caspase Inhibitors
03/18/2010US20100066244 Compound having oxadiazole ring structure substituted with pyridyl group and organic electroluminescence device
03/18/2010US20100066241 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/18/2010CA2737388A1 Methods and compositions for modulating ire1, src, and abl activity
03/18/2010CA2736554A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyrazole methanesulfonate and methods for their preparation
03/18/2010CA2736370A1 Pyrazole carboxamide inhibitors of factor xa
03/18/2010CA2736295A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010CA2735184A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010CA2734034A1 New benzimidazole derivatives
03/18/2010CA2732612A1 Isoquinolinone derivatives as nk3 antagonists
03/17/2010EP2163553A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
03/17/2010EP2163552A1 Indole derivatives and their use as antitumor agents
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP2163544A1 Methods of preparing indazole compounds
03/17/2010EP2162450A1 ((bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
03/17/2010EP2162449A2 Improved process for amorphous rabeprazole sodium
03/17/2010EP2162448A1 Isothiazole and pyrazole derivatives as fungicides
03/17/2010EP2162442A1 Dual-acting benzoimidazole antihypertensive agents
03/17/2010EP2162440A2 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
03/17/2010EP2162436A1 Novel case of renin inhibitors
03/17/2010EP2162433A2 4' substituted compounds having 5-ht6 receptor affinity
03/17/2010EP2162131A1 Quinoline derivatives as pi3 kinase inhibitors
03/17/2010EP2161994A2 Urotensin ii receptor antagonists
03/17/2010EP1966191B1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
03/17/2010EP1846390B1 Novel 6-pyridylphenanthridines
03/17/2010EP1817300B1 Potentiators of glutamate receptors
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/17/2010EP1689742B1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
03/17/2010EP1641423B1 Benzodiazepine cgrp receptor antagonists
03/17/2010EP1620411B1 Inhibitors of akt activity
03/17/2010EP1546133B1 N-substituted-2-oxodihydropyridine derivatives as npy antagonists
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010EP1347955B1 New mandelic acid derivatives and their use as throbin inhibitors
03/17/2010EP1284966B1 Process for the synthesis of amine ethers from secondary amino oxides
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 1080